Cancer Cases - The Need for Cancer Care Overhaul
In the United States, approximately 14 million people have had cancer and more than 1.6 million new cancer cases are diagnosed each year.3 Basic CLL Treatment Options • CCTreatment
CLL Treatment – Chronic lymphocytic leukemia, or CLL cancer, is a type of leukemia that typically affects older adults. This disease begins...Medulloblastoma is the most common type of brain tumor in children. It is a cancer that starts in the lower part of the brain, called the cerebellum. Medulloblastoma can spread to other parts of the brain and spinal cord. Medulloblastoma is a fast-growing tumor. Medulloblastoma can spread to other parts of the brain and spine. One of the most common medulloblastoma symptoms is a headache. Most medulloblastomas are diagnosed in children between the ages of 5 and 9. Medulloblastoma is also found in adults, but it is much less common.
There are four subtypes of medulloblastoma: classic, desmoplastic/nodular, large cell anaplastic, and WNT-driven. The subtype is determined by how the cells look under a microscope. Medulloblastoma is treated with surgery, radiation therapy, and chemotherapy. The treatment type depends on the child's age, the tumor's size and location, and whether the cancer has spread.
There are four subtypes of medulloblastoma: classic, desmoplastic/nodular, large cell anaplastic, and WNT-driven. The subtype is determined by how the cells look under a microscope.
Medulloblastoma can spread to other parts of the brain and spine. One of the most common medulloblastoma symptoms is a headache. Other medulloblastoma symptoms are nausea, vomiting, and double vision.
The cause of medulloblastoma is unknown. However, several risk factors may increase the chance of developing medulloblastoma. There are several risk factors for medulloblastoma, including:
- Age: Medulloblastoma is most common in children between 5 and 9.
- Gender: Medulloblastoma is more common in boys than girls.
- Family history: Having a family member with medulloblastoma increases the risk of developing medulloblastoma.
- Genetic Disorders: Certain genetic disorders, such as neurofibromatosis type 1 and Gorlin syndrome, increase the risk of medulloblastoma.
- Radiation Exposure: Exposure to radiation, such as ionizing radiation, increases the risk of medulloblastoma.
Medulloblastoma is typically diagnosed with a combination of imaging tests and a biopsy. Imaging tests, such as MRI and CT scans, create images of the brain and spine. A biopsy is a procedure in which a tissue sample is removed from the brain or spine and examined under a microscope.
Medulloblastoma is treated with surgery, radiation therapy, and chemotherapy. The treatment type depends on the child's age, the tumor's size and location, and whether the cancer has spread.
Surgery: Surgery is the primary treatment for medulloblastoma. Surgery aims to remove as much of the tumor as possible.
Radiation Therapy: Radiation therapy uses high-energy beams to kill cancer cells. It is typically used after surgery to kill any remaining cancer cells.
Chemotherapy: Chemotherapy uses drugs to kill cancer cells. It is typically used after surgery to kill any remaining cancer cells.
Targeted Therapy: Targeted therapy is a newer treatment that uses drugs or other substances to target specific cancer cells.
The prognosis for medulloblastoma depends on the child's age, the size and location of the tumor, and whether the cancer has spread. In general, children with medulloblastoma have a good prognosis. About 70% of children with medulloblastoma are cured. However, medulloblastoma can come back in some children. Children with medulloblastoma that has spread to other parts of the brain or spine have a lower chance of being cured.
You must be logged in to post a comment.
Recent Comments